The Effect of Betamethasone Combined With Ropivacaine in Paravertebral Block for Postoperative Analgesia After Thoracoscopic Radical Resection of Lung Cancer: a Randomized Controlled Trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900027375

Enrollment

Unknown

Registered

2019-11-11

Start date

2020-01-01

Completion date

Unknown

Last updated

2019-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative analgesia

Interventions

Group B : use betamethasone and ropivacaine

Group R: Use ropivacaine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Diagnosed as "lung cancer", undergoing thoracoscopic radical resection of lung cancer; 2. Aged 40 to 70 years; 3. Body mass index was 18 to 25 kg/m2; 4. The American Society of Anesthesiologists (ASA) classification (anesthesia risk assessment) is I or II level; 5. Patients who voluntary participation in clinical trials and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Obvious cardiopulmonary disease 2. Formulation ingredients used in this study for patients with a history of allergy; 3. Blood system dysfunction; 4. Local skin infectionat the block site, systemic infection; 5. Severe spinal deformities; 6. Pre-existing steroid administration; 7. conversion to open surgery; 8. Endocrine system diseases; 9. Severe liver, kidney dysfunction; 10. Chronic opioid dependence and long-term use of various types of analgesics.

Design outcomes

Primary

Measure	Time frame
VAS scores during coughing;VAS scores in rest;BCS Comfort rating;Quality of recovery;	—

Secondary

Measure	Time frame
postoperative analgesia satisfaction;	—

Countries

China

Contacts

Public ContactHuankai Zhang

Jieyang People's Hospital

13925603360@163.com+86 13925603360

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026